浆细胞性乳腺炎的免疫学研究进展
详细信息    查看全文 | 推荐本文 |
  • 英文篇名:Immunological research progress of plasma cell mastitis
  • 作者:尤广宁 ; 曹中伟
  • 英文作者:You Guangning;Cao Zhongwei;
  • 关键词:浆细胞性乳腺炎 ; 免疫学 ; 白细胞介素2 ; 肿瘤坏死因子 ; 细胞间粘附分子-1
  • 英文关键词:Plasma cell mastitis;;Immunology;;IL-2;;TNF-α;;ICAM-1
  • 中文刊名:ZGLX
  • 英文刊名:Chinese Journal of Convalescent Medicine
  • 机构:内蒙古科技大学包头医学院;
  • 出版日期:2019-04-17
  • 出版单位:中国疗养医学
  • 年:2019
  • 期:v.28
  • 语种:中文;
  • 页:ZGLX201904017
  • 页数:4
  • CN:04
  • ISSN:13-1332/R
  • 分类号:51-54
摘要
浆细胞性乳腺炎(plasma cell mastitis,PCM),是一种主要发生在非泌乳期和非妊娠期的特殊类型的乳腺炎。本病病因不明,治疗效果欠佳,易复发。国内外学者近年来对于本病的病因有不同方向的探究,相当部分的学者认为本病是一种免疫相关性疾病。本文从白细胞介素2(Interleukin-2,IL-2)、肿瘤坏死因子-α(TNF-α)、IL-1β、白细胞介素-6(IL-6)和细胞间粘附分子-1(ICAM-1)5个因子出发,对近年来不同学者对于PCM在免疫学上的发展进行阐述。
        Plasma cell mastitis(PCM) is a special type of mastitis that occurs mainly in non-lactating and non-pregnant periods.The cause of this disease is unknown and the treatment effect is not good and easy to relapse.In recent years,many scholars at home and abroad have explored the causes of this disease in different directions.A considerable number of scholars believe that this disease is an immune-related disease.Based on the five factors of IL-2,TNF-α,IL-1β,IL-6 and ICAM-1,the immunological development of plasma cell mastitis by different scholars in recent years is described.L-1β,IL-6 and ICAM-1,the immunological development of plasma cell mastitis by different scholars in recent years is discussed.
引文
[1]倪毅,殷飞,薛博瑜,等.中西医结合治疗浆细胞性乳腺炎90例[J].南京中医药大学学报,2013,29(3):220-222.
    [2]Patey DH,Thackray AC.Pathology and treatment of mammary-duct fistula[J].Lancet,1958,7052(2):871-873.
    [3]Kessler E,Woolloch Y.Granulomatous mastitis:a lesion clinically simulating carcinoma[J].Am J Clin Pathol,1972(58):642-643.
    [4]郭双平,杨守京,王映梅,等.巴细胞性乳腺炎七例[J].中华病理学杂志,2001,30(5):390-391.
    [5]张大庆.人浆细胞性乳腺炎小鼠模型的建立[D].银川:宁夏医科大学,2012.
    [6]崔振,余建军,张大庆,等.浆细胞性乳腺炎小鼠模型的建立[J].中华全科医学,2013,11(12):1831-1832.
    [7]孙厚启.IL-2、IL-4在浆细胞性乳腺炎组织中的表达及意义[D].石河子:石河子大学,2015.
    [8]张.疮灵液基于解毒收敛改善浆细胞性乳腺炎疮面炎症以促进愈合临床研究[D].南京:南京中医药大学,2017.
    [9]王小龙,刘兴,苏依图,等.浆细胞性乳腺炎组织中IL-1β及TNF-α的表达及临床意义[J].现代生物医学进展,2017,17(6):1110-1112.
    [10]王孟菲.血解毒化痰法对浆细胞性乳腺炎患者的Hs-CRP、PRL及细胞因子IL-1β、IL-6、TNF-α的影响[D].合肥:安徽中医药大学,2015.
    [11]Faccin M,Caillot O,Leveque J,et al.Plasma cell mastitis in women with rheumatoid arthritis treated with TNFαantagonists:Report of 2 cases[J].Joint Bone Spine,2016,5(83):593-594.
    [12]Pasi S,Kant R,Gupta S,et al.Novel multimeric IL-1 receptor antagonist for the treatment of rheumatoid arthritis[J].Biomaterials,2015(42):121-133.
    [13]Rachael S,Watson Levings,Andrew D,et al.Self-Comple-???mentary Adeno-Associated Virus-Mediated Interleukin-1 Receptor Antagonist Gene Delivery for the Treatment of Osteoarthritis:Test of Efficacy in an Equine Model[J].Human Gene Therapy Clinical Development,2018,29(2):101-112.
    [14]Culig Z.Cytokine disbalance in common human cancers[J].Biochim Biophys Acta,2011,18(13):308-314.
    [15]Liu Y,Zhang J,Zhou YH,et al.IL-6/STAT3 signaling pathway is activated in plasma cell mastitis[J].Int J Clin Exp Pathol,2015,8(10):12541-12548.
    [16]Ming J,Meng G,Yuan Q,et al.Clinical characteristics and surgical modality of plasma cell mastitis:analysis of 91cases[J].Am Surg,2013(79):54-60.
    [17]Liu Y,Zhang J,Zhou YH,et al.Activation of the IL-6/JAK2/STAT3 pathway induces plasma cell mastitis in mice[J].Cytokine,2018(110):150-158.
    [18]Burt AD,Le Bail B,Balabaud C,et al.Morphologic investigation of sinusoidal cells[J].Semin Liver Dis,1993,13(1):21-38.
    [19]Dong Y,Yu JJ,Shibahara Y,et al.Inter cellular adhesion molecule 1/2 and E-selectin in plasma cell mastitis:immunohistochemical study of 35 case[J].Hum Pathol,2014,45(3):606-610.
    [20]王华,倪青,高宇哲,等.NF-κBp65、ICAM-1和s ICAM-1在浆细胞性乳腺炎中的表达及意义[J].广东医学,2016,37(21):3208-3211.
    [21]孙勇,佟玉文,徐海燕,等.血清ICAM-1、s ICAM-1、hs-CRP在浆细胞性乳腺炎中的表达及临床意义[J].国际检验医学杂志,2018,39(6):658-660.
NGLC 2004-2010.National Geological Library of China All Rights Reserved.
Add:29 Xueyuan Rd,Haidian District,Beijing,PRC. Mail Add: 8324 mailbox 100083
For exchange or info please contact us via email.